The negative regulators of the host immune response: an unexplored pathway in preterm birth

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 3, 2009, Pages 284.e1-284.e7

  Lyttle, Brianna ^a   Chai, Jinghua ^a   Gonzalez, Juan M ^a   Xu, Hua ^a   Sammel, Mary ^a   Elovitz, Michal A ^a  

^a Ctr for Res on Repro and W H   (United States)

Author keywords

interleukin receptor associated kinase; medroxyprogesterone acetate; preterm birth; Toll like receptor

Indexed keywords

DIMETHYL SULFOXIDE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; LIPOPOLYSACCHARIDE; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; SODIUM CHLORIDE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PATHOGENESIS; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SPLEEN; UTERINE CERVIX;

EID: 69349091075     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.05.053     Document Type: Article

References (46)

1. Elovitz M.A. Anti-inflammatory interventions in pregnancy: now and the future. Semin Fetal Neonatal Med 11 (2006) 327-332
2. Elovitz M.A., and Mrinalini C. Animal models of preterm birth. Trends Endocrinol Metab 15 (2004) 479-487
3. Goldenberg R.L., Hauth J.C., and Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 342 (2000) 1500-1507
4. Goncalves L.F., Chaiworapongsa T., and Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 8 (2002) 3-13
5. Dammann O., and Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42 (1997) 1-8
6. Hirsch E., Blanchard R., and Mehta S.P. Differential fetal and maternal contributions to the cytokine milieu in a murine model of infection-induced preterm birth. Am J Obstet Gynecol 180 (1999) 429-434
7. Yoon B.H., Romero R., Yang S.H., et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174 (1996) 1433-1440
8. Wang X., Hagberg H., Mallard C., et al. Disruption of interleukin-18, but not interleukin-1, increases vulnerability to preterm delivery and fetal mortality after intrauterine inflammation. Am J Pathol 169 (2006) 967-976
9. Yoshimura K., and Hirsch E. Interleukin-6 is neither necessary nor sufficient for preterm labor in a murine infection model. J Soc Gynecol Investig 10 (2003) 423-427
10. Yoshimura K., and Hirsch E. Effect of stimulation and antagonism of interleukin-1 signaling on preterm delivery in mice. J Soc Gynecol Investig 12 (2005) 533-538
11. Gonzalez J.M., Xu H., Ofori E., and Elovitz M.A. Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state?. Am J Obstet Gynecol 197 (2007) 296e1-6
12. Abrahams V.M., Bole-Aldo P., Kim Y.M., et al. Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol 173 (2004) 4286-4296
13. Elovitz M.A., Wang Z., Chien E.K., Rychlik D.F., and Phillippe M. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 163 (2003) 2103-2111
14. Wang H., and Hirsch E. Bacterially induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4. Biol Reprod 69 (2003) 1957-1963
15. Gottipati S., Rao N.L., and Fung-Leung W.P. IRAK1: a critical signaling mediator of innate immunity. Cell Signal 20 (2008) 269-276
16. Gan L., and Li L. Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity. Immunol Res 35 (2006) 295-302
17. Dillon S., Agrawal A., Van Dyke T., et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172 (2004) 4733-4743
18. Echchannaoui H., Frei K., Schnell C., Leib S.L., Zimmerli W., and Landmann R. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 186 (2002) 798-806
19. Fukata M., Michelsen K.S., Eri R., et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288 (2005) G1055-G1065
20. Chen G., Shi J., Jin W., et al. Progesterone administration modulates TLRs/NF-kappaB signaling pathway in rat brain after cortical contusion. Ann Clin Lab Sci 38 (2008) 65-74
21. Kobayashi K., Hernandez L.D., Galan J.E., Janeway Jr. C.A., Medzhitov R., and Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110 (2002) 191-202
22. Zhande R., Dauphinee S.M., Thomas J.A., Yamamoto M., Akira S., and Karsan A. FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction. Mol Cell Biol 27 (2007) 7394-7404
23. Lang T., and Mansell A. The negative regulation of Toll-like receptor and associated pathways. Immunol Cell Biol 85 (2007) 425-434
24. Borysiewicz E., Fil D., and Konat G.W. Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes. J Neurosci Res 87 (2009) 1565-1572
25. Baetz A., Frey M., Heeg K., and Dalpke A.H. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J Biol Chem 279 (2004) 54708-54715
26. Albrecht V., Hofer T.P., Foxwell B., Frankenberger M., and Ziegler-Heitbrock L. Tolerance induced via TLR2 and TLR4 in human dendritic cells: role of IRAK-1. BMC Immunol 9 (2008) 69
27. Balaci L., Spada M.C., Olla N., et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am J Hum Genet 80 (2007) 1103-1114
28. Follett P.L., Deng W., Dai W., et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24 (2004) 4412-4420
29. Balachandran S., Thomas E., and Barber G.N. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432 (2004) 401-405
30. Elovitz M., and Wang Z. Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol 190 (2004) 693-701
31. Elovitz M.A., and Mrinalini C. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?. Am J Obstet Gynecol 193 (2005) 1149-1155
32. Elovitz M.A., and Mrinalini C. The use of progestational agents for preterm birth: lessons from a mouse model. Am J Obstet Gynecol 195 (2006) 1004-1010
33. Elovitz M.A., and Gonzalez J. Medroxyprogesterone acetate modulates the immune response in the uterus, cervix and placenta in a mouse model of preterm birth. J Matern Fetal Neonatal Med 21 (2008) 223-230
34. Elovitz M.A., Mrinalini C., and Sammel M.D. Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth. Pediatr Res 59 (2006) 50-55
35. Fonseca E.B., Celik E., Parra M., Singh M., and Nicolaides K.H. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357 (2007) 462-469
36. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
37. Xu H., Gonzalez J.M., Ofori E., and Elovitz M.A. Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth?. Am J Obstet Gynecol 198 (2008) 314e1-8
38. Yellon S.M., Mackler A.M., and Kirby M.A. The role of leukocyte traffic and activation in parturition. J Soc Gynecol Investig 10 (2003) 323-338
39. Matsuguchi T., Musikacharoen T., Ogawa T., and Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 165 (2000) 5767-5772
40. Matsumura T., Ito A., Takii T., Hayashi H., and Onozaki K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 20 (2000) 915-921
41. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168 (2002) 554-561
42. da Fonseca E.B., Bittar R.E., Carvalho M.H., and Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188 (2003) 419-424
43. O'Brien J.M., Adair C.D., Lewis D.F., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 30 (2007) 687-696
44. Dudley D.J., Branch D.W., Edwin S.S., and Mitchell M.D. Induction of preterm birth in mice by RU486. Biol Reprod 55 (1996) 992-995
45. Reznikov L.L., Fantuzzi G., Selzman C.H., et al. Utilization of endoscopic inoculation in a mouse model of intrauterine infection-induced preterm birth: role of interleukin 1beta. Biol Reprod 60 (1999) 1231-1238
46. Arcaroli J., Silva E., Maloney J.P., et al. Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 173 (2006) 1335-1341